• Home
  • About
  • Members
  • News & Updates
    • News
    • Member Updates
    • Consortium Updates
  • Contact Us
Universal Influenza Vaccine Development
  • Home
  • About
  • Members
  • News & Updates
    • News
    • Member Updates
    • Consortium Updates
  • Contact Us

Archives

Monthly Archive for: "April, 2019"
Home » Archives for April 2019
European Investment Bank (EIB) Extends Financing Agreement to €24 Million Total in Support of BiondVax’s Universal Flu Vaccine Ongoing Pivotal Phase 3 Clinical Trial
By Amanda Bolster
In News
Posted April 26, 2019

European Investment Bank (EIB) Extends Financing Agreement to €24 Million Total in Support of BiondVax’s Universal Flu Vaccine Ongoing Pivotal Phase 3 Clinical Trial

“JERUSALEM, April 22, 2019 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), announced today that the Management Committee of the European Investment Bank (EIB) agreed to [...]

READ MORE
NIH begins first-in-human trial of a universal influenza vaccine candidate
By Amanda Bolster
In News
Posted April 11, 2019

NIH begins first-in-human trial of a universal influenza vaccine candidate

“The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response in [...]

READ MORE

  • Home
  • About
  • Members
  • News & Updates
    • News
    • Member Updates
    • Consortium Updates
  • Contact Us
Privacy Policy | Copyright All Rights Reserved © 2017

Start typing and press Enter to search